Cencora, Inc. (COR) income statement
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$348.31−2.25 (-0.64%)
Close on Nov 18, 2026Market cap $66.47BP/E 25.9Yield 0.63%
Cencora, Inc. financial ratios
See a number that looks wrong?